October 23, 2025

McDermott represents ADAR1 Capital Management, LLC in its campaign at Keros Therapeutics, Inc.

October 23, 2025

McDermott represents Constellation Brands in connection with its $500 million senior notes offering

October 23, 2025

McDermott represents BTG Pactual Strategic Capital and Legent Health in its acquisition by HHS and General Atlantic

October 23, 2025

Cancer: French start-up Adcytherix raises €105 million

22. Oktober 2025

McDermott berät Studio 100 International bei strategischer Allianz mit Animaj

October 22, 2025

McDermott Will & Schulte advises Cosmo5 on the acquisition of Storeis

October 22, 2025

McDermott advises Invesco Real Estate on strategic logistics joint venture with LCP

October 22, 2025

McDermott Will & Schulte advises Ardian Growth on its acquisition of a stake in JPB Système

October 22, 2025

McDermott Will & Schulte advises V-Bio Ventures on €38 million Series C financing of Step Pharma

October 20, 2025

Private Credit's Public Pivot – Crisis Play Or Permanent Shift?

October 17, 2025

Litigator of the week runners-up and shout-outs

17. Oktober 2025

McDermott berät Rhein Invest bei Mehrheitsbeteiligung an MC Shape

October 16, 2025

McDermott represents GoodLeap in an innovative $183 million back-leverage securitization backed by GoodLeap-originated residential solar and battery storage customer agreements

October 16, 2025

Chambers UK 2026 rankings spotlight McDermott Will & Schulte’s expanding London strength

October 2025

2026 budget: Why the tax on holding companies is a ‘disguised’ return of the wealth tax for those affected

October 15, 2025

McDermott Will & Schulte advised EverZom on its €10 million financing round

McDermott Will & Schulte recognized once again for leadership in European restructuring by Turnarounds & Workouts

October 15, 2025

McDermott Will & Schulte’s health & life sciences group recognized by LMG Life Sciences 2025